Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma

NCT01127451 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Stage IIIC Melanoma
Stage IV Melanoma

Interventions

DRUG: Denileukin diftitox

Sponsor

Eisai Inc.

Collaborators

[object Object]